Results 221 to 230 of about 174,530 (347)

Reduced <i>GEN1</i> Expression Is Associated with Elevated DNA Damage and Impaired Proliferation in Endometriosis-Derived Endometrial Organoids. [PDF]

Int J Mol Sci
Guzelbag B, Gungor NE, Karahan H, Maghsoudi A, Oral E.   +4 more
europepmc   +1 more source

Assessing Variability in Microrna Concentrations in Serum Throughout the Menstrual Cycle in Women with and Without Endometriosis

, 2019
Victoria Turpin
openalex   +1 more source

Hiding in plain sight: DICER1‐associated yolk sac tumour masquerading as an endometrioid carcinoma of the ovary

Histopathology, EarlyView.
Lili Fu, Afrida Ahmed, Celine Domecq, Elizabeth N Skinner, William D Foulkes   +4 more
wiley   +1 more source

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy

The Journal of Pathology: Clinical Research, Volume 12, Issue 3, May 2026.
Abstract Mirvetuximab‐soravtansine (MIRV‐S) is an antibody‐drug conjugate targeting folate receptor alpha (FOLR1). MIRV‐S is approved for the treatment of FOLR1‐positive, platinum‐resistant ovarian carcinoma. Patient eligibility is determined by immunohistochemistry (IHC) using a companion diagnostic (CDx) assay (FOLR1‐2.1, Ventana).
Annika Nasdala, Leonie D Kandt, Martin Radner, Nora Schaumann, Malte Gronewold, Pia Hillmann, Henriette Christgen, Jens Hachenberg, Elna Kuehnle, Christian Hartmann, Matthias Christgen   +10 more
wiley   +1 more source

Endo-SOFT: study protocol for a national multicentre randomised controlled trial - first-line surgery versus first-line assisted reproductive technologies in patients with advanced endometriosis. [PDF]

BMJ Open
Marklund A, Wängberg Nordborg J, Asciutto C, Elenis E, Francis J, Jokubkiene L, Wennmo Zuk K, Åmark H, Rodriguez-Wallberg KA, Sundfeldt K, Forslund M, Brunes M.   +11 more
europepmc   +1 more source

CNC–PNIPAM Drug Delivery System Improves Endometrial Receptivity via Natural Killer Cell Immune Tolerance in Endometriosis

Advanced NanoBiomed Research, Volume 6, Issue 5, May 2026.
An injectable CNC–PNIPAM hydrogel is developed for intrauterine co‐delivery of levonorgestrel and botropase. This platform reprograms uterine natural killer cells toward an immune–tolerant phenotype and enhances endometrial receptivity marker expression. The results demonstrate a promising strategy to counteract endometriosis–associated infertility and
Zhou Liang, Yingjie Wang, Chenyu Bai, Pengfei Li, Xin He, Meng Ma, Xiaoying Luo, Yi Song, Yao Li, Yun Wang   +9 more
wiley   +1 more source

Coexistence of Ovarian Mature Cystic Teratomas and Endometriosis: An Update. [PDF]

Int J Womens Health
Lin C, Chae HS.
europepmc   +1 more source

Development of a subcutaneous endometriosis rat model [PDF]

, 2015
Francisco Edson Ximenes Gomes Pereira, Paulo Roberto Carvalho de Almeida, Bruno Hállan Meneses Dias, Paulo Roberto Leitão de Vasconcelos, Sérgio Botelho Guimarães, Francisco das Chagas Medeiros   +5 more
openalex   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

Robotic Single-Incision Laparoscopic Surgery for the Management of Endometriosis: First Experience Via the Da Vinci SP Platform. [PDF]

Int J Med Robot
Yang Q, Lovell DY, Guan X.
europepmc   +1 more source